Ruidong Mo

540 total citations
15 papers, 392 citations indexed

About

Ruidong Mo is a scholar working on Epidemiology, Hepatology and Pharmacology. According to data from OpenAlex, Ruidong Mo has authored 15 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 6 papers in Hepatology and 3 papers in Pharmacology. Recurrent topics in Ruidong Mo's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (8 papers) and Liver Disease and Transplantation (3 papers). Ruidong Mo is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (8 papers) and Liver Disease and Transplantation (3 papers). Ruidong Mo collaborates with scholars based in China, Australia and United States. Ruidong Mo's co-authors include Xiaogang Xiang, Qing Xie, Shisan Bao, Hui Wang, Jie Lu, Rongtao Lai, Xiaolin Wang, Gangde Zhao, Bin Gao and Seonghwan Hwang and has published in prestigious journals such as Journal of Hepatology, Theranostics and Oncotarget.

In The Last Decade

Ruidong Mo

13 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruidong Mo China	9	263	179	84	67	49	15	392
Beatriz Barranco-Fragoso Mexico	8	327 1.2×	228 1.3×	37 0.4×	34 0.5×	59 1.2×	13	432
Zhujun Cao China	14	379 1.4×	289 1.6×	62 0.7×	61 0.9×	68 1.4×	40	518
X Volkmann Germany	7	312 1.2×	236 1.3×	51 0.6×	73 1.1×	82 1.7×	7	503
Jin-Seok Byun South Korea	8	165 0.6×	154 0.9×	122 1.5×	17 0.3×	44 0.9×	9	351
Emma Louise Haughton United Kingdom	6	173 0.7×	263 1.5×	106 1.3×	49 0.7×	129 2.6×	11	461
Chongyang Zhang China	6	290 1.1×	289 1.6×	34 0.4×	38 0.6×	92 1.9×	10	516
G. Marquitan Germany	10	207 0.8×	122 0.7×	80 1.0×	29 0.4×	38 0.8×	12	386
Jayashree Bagchi Chakraborty United Kingdom	5	153 0.6×	120 0.7×	111 1.3×	42 0.6×	31 0.6×	5	328
Julia Maltby United Kingdom	3	164 0.6×	153 0.9×	71 0.8×	38 0.6×	27 0.6×	4	324
Xiang‐An Zhao China	10	152 0.6×	114 0.6×	111 1.3×	19 0.3×	29 0.6×	17	322

Countries citing papers authored by Ruidong Mo

Since Specialization

Citations

This map shows the geographic impact of Ruidong Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruidong Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruidong Mo more than expected).

Fields of papers citing papers by Ruidong Mo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruidong Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruidong Mo. The network helps show where Ruidong Mo may publish in the future.

Co-authorship network of co-authors of Ruidong Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Ruidong Mo. A scholar is included among the top collaborators of Ruidong Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruidong Mo. Ruidong Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Mo, Ruidong, Nan Jia, Y. X. Song, et al.. (2025). Safety and efficacy of rush immunotherapy using house dust mite after one dose of anti-IgE pretreatment. Chinese Science Bulletin (Chinese Version). 71(5-6). 1184–1193.

Mo, Ruidong, et al.. (2025). A new prognostic model based on serum apolipoprotein AI in patients with HBV-ACLF and acutely decompensated liver cirrhosis. Lipids in Health and Disease. 24(1). 35–35.

Lai, Rongtao, Yan Huang, Ruidong Mo, et al.. (2023). Clinic-radiomics model using liver magnetic resonance imaging helps predict chronicity of drug-induced liver injury. Hepatology International. 17(6). 1626–1636. 3 indexed citations

Wang, Peng, Weiliang Tang, Ruidong Mo, et al.. (2022). Genetic Variations of ALDH (rs671) Are Associated With the Persistence of HBV Infection Among the Chinese Han Population. Frontiers in Medicine. 9. 811639–811639. 8 indexed citations

Zhang, Jinming, Jing Xu, Weiliang Tang, et al.. (2022). Clinical characteristics and pathogen spectra of parasitic infections in a tertiary hospital of Shanghai: A 13-year retrospective study. Frontiers in Public Health. 10. 993377–993377. 3 indexed citations

Zhang, Jinming, Pei Yu, Ruidong Mo, et al.. (2022). Human Umbilical Cord Blood Mononuclear Cells Ameliorate CCl4-Induced Acute Liver Injury in Mice via Inhibiting Inflammatory Responses and Upregulating Peripheral Interleukin-22. Frontiers in Pharmacology. 13. 924464–924464. 4 indexed citations

Xiang, Xiaogang, Dechun Feng, Seonghwan Hwang, et al.. (2019). Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice. Journal of Hepatology. 72(4). 736–745. 131 indexed citations

Mo, Ruidong, Rongtao Lai, Jie Lu, et al.. (2018). Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injury. Theranostics. 8(15). 4170–4180. 54 indexed citations

Ren, Peipei, Zhujun Cao, Ruidong Mo, et al.. (2018). Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk. Expert Opinion on Biological Therapy. 18(10). 1085–1094. 27 indexed citations

10.

Wang, Peng, Xiaogang Xiang, Ruidong Mo, et al.. (2017). Serum soluble ST2 is a promising prognostic biomarker in HBV-related acute-on-chronic liver failure. Hepatobiliary & pancreatic diseases international. 16(2). 181–188. 8 indexed citations

11.

Cao, Zhujun, Ziqiang Li, Hui Wang, et al.. (2017). Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection. Liver International. 37(11). 1612–1621. 41 indexed citations

12.

Cao, Zhujun, Y. Wang, Yue Liu, et al.. (2017). Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection. Journal of Viral Hepatitis. 24(S1). 57–65. 26 indexed citations

13.

Wang, Peng, Ruidong Mo, Rongtao Lai, et al.. (2017). Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinoma. Oncotarget. 8(62). 105407–105424. 17 indexed citations

14.

Mo, Ruidong, Peng Wang, Rongtao Lai, et al.. (2016). Persistently elevated circulating Th22 reversely correlates with prognosis in HBV‐related acute‐on‐chronic liver failure. Journal of Gastroenterology and Hepatology. 32(3). 677–686. 23 indexed citations

15.

Lai, Rongtao, Xiaogang Xiang, Ruidong Mo, et al.. (2015). Protective effect of Th22 cells and intrahepatic IL-22 in drug induced hepatocellular injury. Journal of Hepatology. 63(1). 148–155. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact